ArticleFASEB bioAdvances2022

Inhibition of insulin-like growth factor 2 mRNA-binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics.

Nicole Betson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.